EUVIMED · CrossrefZeitschrift
The Lancet Respiratory Medicine
ISSN 2213-2600 · Elsevier BV
Neueste Artikel
Ending the global neglect of pneumonia: from awareness to accountability
Breathlessness mechanisms, measurement, and management in adults: evidence update on behalf of The Dyspnoea Society
Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study
Obstructive sleep apnoea: an overlooked challenge in the current NHS Strategy
Consensus on the definition, components, and grading of composite postoperative pulmonary complication outcomes (PrECiSIOn): insights from an international Delphi expert panel
Defining residual lung disease with CFTR modulators
Laennec beyond the stethoscope
RSV multidose vaccine puts Africa's RSV burden in focus
The present and future of chronic obstructive pulmonary disease prevention, diagnosis, and management in China: a Lancet Respiratory Medicine Commission
Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension
From coverage to equitable reach: addressing social inequalities in COPD in China
Reshaping COPD care in China: bridging geographical divides and empowering health-care workers
Twice-yearly depemokimab: beyond dosing convenience
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
Sugammadex versus neostigmine and postoperative pulmonary complications: a word of caution
Contributors to the heterogeneity of response to CFTR modulators
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study
Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study
Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries
Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study
Biology meets physiology in ARDS precision medicine
2026 GINA report for asthma
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study
Non-invasive respiratory supports and criteria for intubation in randomised trials of acute hypoxaemic respiratory failure: a systematic review and network meta-analysis
Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes
PET–CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial
EUVIMED